Table 3. Baseline and training-induced changes in the four risk factors for the five cohorts (mean ± SD).
HERITAGE | DREW | INFLAME | STRRIDE | Maryland | Jyvaskyla | ||||
Variable | Whites (n≤473) | Blacks (n≤250) | 4 kcal/kg/wk (n≤143) | 8 kcal/kg/wk (n≤89) | 12 kcal/kg/wk (n≤94) | (n≤70) | (n≤303) | (n≤160) | (n≤105) |
Baseline fasting insulin, pmol/L | 65.7±40.0 | 79.7±63.2 | 74±41.24 | 75.85±42.34 | 70.93±41.08 | 82.30±40.77 | −65.3±41.8 | 83±31 | 31.6±16.7 |
Change in fasting insulin, pmol/L | −5.2±24.9††† | −10.8±44.6††† | −2.02±31.06 | −7.98±27.59† | −1.95±29.54 | −5.58±31.33 | −11.6±29.1††† | −11±21††† | −3.2±14.0 |
Baseline HDL-C, mmol/L | 1.04±0.26 | 1.09±0.32 | 1.50±0.38 | 1.49±0.40 | 1.50±0.35 | 1.50±0.39 | 1.17±0.35 | 1.24±0.41 | 1.28±0.40 |
Change in HDL-C, mmol/L | 0.04±0.12††† | 0.03±0.13††† | −0.01±0.21 | −0.01±0.21 | −0.04±0.20 | −0.05±0.14†† | 0.04±0.16 | 0.08±0.21††† | 0.01±0.21 |
Baseline Tg, mmol/L | 1.38±0.78 | 1.04±0.62 | 1.45±0.67 | 1.47±0.68 | 1.44±0.81 | 1.28±0.56 | 1.72±0.89 | 1.67±1.08 | 1.19±0.71 |
Change in Tg, mmol/L | −0.02±0.42 | −0.03±0.41 | −0.08±0.47 | −0.02±0.50 | 0.03±0.56 | 0.00±0.46 | −0.24±0.64†† | −0.21±0.74††† | −0.11±0.54† |
Baseline SBP, mm Hg | 116.2±10.9 | 122.8±12.0 | 138.9±13.4 | 139.9±13.6 | 138.5±12.7† | 131.3±20.4 | N/A | 133 + 16 | 131.7±15.6 |
Change in SBP, mm Hg | 0.2±6.2 | −1.2±7.8† | 1±12.7 | −1.6±15.1 | −3.1±11.8 | −4.3±13.8† | N/A | 1 + 13 | −3.7±10.9†† |
p≤0.05.
p<0.01.
p<0.001 indicates significant change score within a group.
To convert pmol/L of insulin to mU/L, divide by 6.945. To convert mmol/L of HDL-C to mg/dL, divide by 0.02586. To convert mmol/L of triglycerides to mg/dl, divide by 0.01129.